KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Price, Quote, News and Overview
NASDAQ:KZIA - Nasdaq - US48669G2049 - ADR - Currency: USD
KZIA Quote, Performance and Key Statistics
KAZIA THERAPEUTICS-SPON ADR
NASDAQ:KZIA (2/5/2025, 8:10:49 PM)
After market: 1.4191 +0.02 (+1.36%)1.4
0 (0%)
The current stock price of KZIA is 1.4 USD. In the past month the price decreased by -22.22%. In the past year, price decreased by -48.38%.
KZIA Latest News, Press Releases and Analysis
What's going on in today's session
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Which stocks are gapping on Friday?
Let's have a look at the gap up and gap down stocks in today's session.
Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) an oncology-focused drug development company, is pleased to announce the regulatory approval and...
Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has...
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has...
KZIA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.95 | 338.85B | ||
| AMGN | AMGEN INC | 15.53 | 165.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 957.73 | 125.79B | ||
| GILD | GILEAD SCIENCES INC | 22.49 | 124.19B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.7 | 78.76B | ||
| ARGX | ARGENX SE - ADR | N/A | 40.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.64B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.34B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.26B | ||
| NTRA | NATERA INC | N/A | 23.37B | ||
| BIIB | BIOGEN INC | 8.91 | 21.21B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.55 | 15.81B |
Related stock screener links
About KZIA
Company Profile
Kazia Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Sydney, New South Wales. Kazia Therapeutics Limited is an oncology focused drug development company. The firm is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.
Company Info
KAZIA THERAPEUTICS-SPON ADR
Three International Towers Level 24,, 300 Barangaroo Avenue
Sydney NEW SOUTH WALES 2000 AU
CEO: James Garner
Employees: 13
Company Website: https://www.kaziatherapeutics.com/
Investor Relations: http://www.novogen.com/investorcentre
Phone: 1161298780088
KZIA FAQ
What is the stock price of KZIA?
The current stock price of KZIA is 1.4 USD.
What is the symbol for KAZIA THERAPEUTICS-SPON ADR stock?
The exchange symbol of KAZIA THERAPEUTICS-SPON ADR is KZIA and it is listed on the Nasdaq exchange.
On which exchange is KZIA stock listed?
KZIA stock is listed on the Nasdaq exchange.
Is KZIA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for KZIA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of KZIA.
Does KZIA stock pay dividends?
KZIA does not pay a dividend.
When does KZIA stock report earnings?
KZIA will report earnings on 2025-02-20.
What is the Price/Earnings (PE) ratio of KZIA?
KZIA does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.52).
What is the Short Interest ratio of KZIA stock?
The outstanding short interest for KZIA is 1.17% of its float.
KZIA Technical Analysis
KZIA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KZIA. KZIA may be in some trouble as it scores bad on both profitability and health.
KZIA Financial Highlights
Over the last trailing twelve months KZIA reported a non-GAAP Earnings per Share(EPS) of -3.52. The EPS decreased by 92.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -124.06% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
KZIA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the average rating of analysts ratings from 7 analysts.